Get the Stockscreener App
17.84
6.40%
-1.22
After Hours:
17.88
0.04
+0.22%
Mediwound Ltd stock is traded at $17.84, with a volume of 208.50K.
It is down -6.40% in the last 24 hours and down -4.95% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$19.06
Open:
$18.94
24h Volume:
208.50K
Relative Volume:
2.33
Market Cap:
$192.81M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-12.93
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
+9.52%
1M Performance:
-4.95%
6M Performance:
+0.00%
1Y Performance:
+1.31%
1-Day Range:
$17.55
$19.06
1-Week Range:
$16.08
$20.30
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.84 | 200.66M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
Real time breakdown of MediWound Ltd. stock performanceBreakout Watch & Real-Time Volume Analysis Alerts - Newser
Real time pattern detection on MediWound Ltd. stockJuly 2025 Retail & AI Forecasted Entry and Exit Points - Newser
Does MediWound Ltd. show high probability of rebound2025 AllTime Highs & Accurate Entry/Exit Alerts - Newser
How to use Fibonacci retracement on MediWound Ltd.Weekly Trend Report & AI Enhanced Execution Alerts - Newser
How to build a dashboard for MediWound Ltd. stockWeekly Trend Summary & Long Hold Capital Preservation Tips - Newser
Key resistance and support levels for MediWound Ltd.2025 EndofYear Setup & Low Risk High Reward Ideas - Newser
Will MediWound Ltd. bounce back from current supportWeekly Stock Report & Short-Term High Return Ideas - Newser
Applying Elliott Wave Theory to MediWound Ltd.Product Launch & Daily Entry Point Alerts - Newser
What indicators show strength in MediWound Ltd.July 2025 Final Week & Reliable Volume Spike Trade Alerts - Newser
Using data filters to optimize entry into MediWound Ltd.Earnings Miss & Real-Time Volume Triggers - Newser
What earnings revisions data tells us about MediWound Ltd.Buy Signal & Risk Controlled Stock Alerts - Newser
Chart based analysis of MediWound Ltd. trends2025 Market WrapUp & Low Drawdown Investment Ideas - Newser
Strategies to average down on MediWound Ltd.2025 Historical Comparison & Reliable Price Breakout Signals - Newser
Relative strength of MediWound Ltd. in sector analysisWeekly Stock Recap & Safe Investment Capital Preservation Plans - Newser
What’s the recovery path for long term holders of MediWound Ltd.July 2025 Snapshot & AI Forecasted Stock Moves - Newser
How to forecast MediWound Ltd. trends using time series2025 Top Gainers & High Yield Stock Recommendations - Newser
Published on: 2025-09-09 23:26:29 - Newser
Analyzing recovery setups for MediWound Ltd. investorsJuly 2025 Short Interest & Low Risk High Win Rate Picks - Newser
Signal strength of MediWound Ltd. stock in tech scannersQuarterly Trade Summary & Daily Price Action Insights - Newser
relative strength of mediwound ltd. in sector analysisQuarterly Profit Review & Capital Efficiency Focused Strategies - Newser
Can momentum traders help lift MediWound Ltd.Entry Point & Expert Curated Trade Setup Alerts - Newser
How high can MediWound Ltd. stock go2025 Earnings Surprises & Daily Technical Stock Forecast Reports - Newser
Published on: 2025-09-09 06:20:31 - beatles.ru
What’s next for MediWound Ltd. stock priceJuly 2025 Market Mood & Accurate Intraday Trade Tips - Newser
MediWound at H.C. Wainwright Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Is It Too Early to Call Recovery in MediWound Ltd.July 2025 Momentum & Verified High Yield Trade Plans - beatles.ru
MediWound at H.C. Wainwright Conference: Strategic Growth and Challenges - Investing.com
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):